0 items USD 0.00Search
Your search for "gir global insulin lispro market 2019 manufacturers regions type application forecast 2024" gave back 819845 results.
The global Insulin Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Insulin Lispro market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin Lispro is forecast to...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biosimilar Insulin market size was valued at USD 2632.1 million in 2023 and is forecast to a readjusted size of USD 6421.8 million by 2030...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The main component of recombinant insulin lispro injection is insulin lispro, which is a human insulin analog produced by genetic recombination...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the '...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Fast-acting Human Insulin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
November 2023
Price: USD 3,480.00
The global Biosimilar Insulin market size was valued at US$ 2502.4 million in 2023. With growing demand in downstream market, the Biosimilar Insulin...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Fast-acting Human Insulin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global Fast-acting Human Insulin market size was valued at US$ million in 2022. With growing demand in downstream market, the Fast-acting Human...
Catalog:
LPI
November 2023
Price: USD 3,660.00
According to publisher’s new survey, global Fast-acting Human Insulin market is projected to reach US$ million in 2029, increasing from US$ million...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Ultra Short Acting Insulin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of %...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
